Immunomedics Says SC Veltuzumab Produced High Response Rate In Relapsed ITPNASDAQResponses occurred across all doses tested, including the lowest dose at 80 mg, regardless of the route of administration, history of splenectomy or prior use of rituximab…
Fractionated 90 Y-Ibritumomab Tiuxetan Effective as First-Line Therapy for …Monthly Prescribing ReferencePatients with >20% bone marrow (BM) involvement received fractionated RIT only if a repeat BM biopsy demonstrated a reduction to ≤20% involv…
Excellent PFS and OS Observed with CHOP Combination Regimens in Newly …Monthly Prescribing ReferenceThe CHOP-R arm of patients received six cycles of CHOP chemotherapy (cyclophosphamide 750mg/m 2 , doxorubicin 50mg/m 2 , vincristine 1.4mg/m 2 , and p…
The Oncology ReportRe-treatment strategy challenges maintenance therapy for rituximab use in low …HemOncTodaySAN DIEGO — Patients with low tumor burden follicular lymphoma who received a maintenance dose of rituximab every 3 months did not have a l…
Impressive ZEVALIN® Data Highlighted at 53rd Annual Meeting of the American …TradersHuddle.com (press release)The authors have previously demonstrated that R-FND (rituximab, fludarabine, mitoxantrone, and dexamethasone) is an effective regimen for i…
Intensive chemotherapy greatly improved survival for lymphoma patientsOncology Nurse AdvisorGroupe d'Etude des Lymphomes de l'Adulte and Amgen funded the open-label randomized trial in which Groupe investigators compared two regimens: dose-inte…
ASH: Rituximab Dosing Schemes Prove Equal in Low-Burden FLMedPage TodayExplain that maintenance therapy with rituximab (Rituxan) in low-burden follicular lymphoma provided disease control that was as good as rituximab retreatment at progression. Point …
Rituximab and Liposomal Doxorubicin Improve Progression-Free and Overall …Monthly Prescribing ReferenceSAN DIEGO, CA—At the 53rd American Society of Hematology Annual Meeting and Exposition, study investigators presented evidence demonstrating prom…
R-BAC Effective In Patients With Mantle Cell Lymphoma Not Eligible for …Monthly Prescribing ReferenceSAN DIEGO, CA—The rituximab, bendamustine, and cytarabine (R-BAC) chemotherapy regimen was shown to be effective in previously untreated patients &…
Rituximab Plus Pulse Dexamethasone Effective, Tolerable in Patients with …Monthly Prescribing ReferenceSAN DIEGO, CA—Standard-dose rituximab plus multiple courses of pulse dexamethasone was shown to be active with manageable toxicity in patients wi…